Tech Triumphs, Retail Stumbles: Mixed Pre-Market Signals for London

📈 Today's Key Themes

Pre-market updates paint a picture of contrasting fortunes across London-listed companies, setting the stage for a mixed opening on the LSE. The technology and healthcare sectors are showing strength, with companies like Cerillion and Shield Therapeutics reporting robust growth. However, the retail sector faces significant headwinds, as evidenced by Shoe Zone's disappointing results. Meanwhile, strategic corporate actions, such as Redcentric's sizeable data centre sale, add an element of intrigue to the market landscape. These divergent performances reflect the complex economic environment, with some sectors thriving while others grapple with ongoing challenges.

💡 Company Updates

Trading Updates

Shield Therapeutics (#STX) reported a stellar Q3 2025 performance, with ACCRUFeR® net revenues surging over 80% year-on-year to £13.1 million. The company's prescription volumes reached around 54,000, with a higher average net selling price of £237. Shield remains on track to turn cash flow positive by the end of 2025, with £8.6 million in cash as of 30 September 2025. The very positive sentiment surrounding this update suggests potential upside for the stock. Cerillion (#CER) delivered an impressive full-year trading update, with total new orders reaching a record £47.6 million, up 25% year-on-year. Revenue is expected to be around £45.3 million, up from £43.8 million in the prior year, while adjusted profit before tax is anticipated to be slightly ahead of the consensus market forecast of £20.5 million. The company's strong performance and positive outlook could drive investor interest in the technology sector. Hunting (#HTG) reported a 15% year-on-year increase in EBITDA to approximately £100.5 million for Q3 2025, with an EBITDA margin of around 13%. However, the company expects its 2025 EBITDA outturn to be at the lower end of guidance, indicating some caution in its outlook. This mixed update may lead to varied investor reactions. Shoe Zone (#SHOE) delivered disappointing results, with revenue declining 7.6% to £149.1 million and adjusted profit before tax expected to be around £2.4 million, down from £10.0 million in the previous year. The company cited challenging market conditions and higher costs as key factors behind the weaker performance. This negative update could put pressure on Shoe Zone's stock and potentially impact sentiment towards the broader retail sector.

🎯 Leading Developments

Redcentric (#RCN) has agreed to sell its data centre business for up to £127 million, allowing the company to focus on its higher-margin managed services division. The proceeds will be used for debt reduction, shareholder returns, and growth in the MSP segment. This strategic move could be viewed positively by investors, as it streamlines Redcentric's business model and potentially enhances its financial flexibility.

The disposal of Redcentric's data centre business for up to £127 million is a positive outcome for the company, as it allows management to focus on the higher-margin MSP division and provides funds to reduce debt and return capital to shareholders.

Arbuthnot Banking Group (#ARBB) reported mixed performance in its Q3 2025 trading update. While Funds under Management and Administration grew 24% year-on-year to £2.5 billion, customer loans and leased assets declined by 9% over the previous 12 months. The uncertain economic outlook and anticipation of the Autumn Budget have dampened sentiment and activity across the bank's divisions. This update reflects the challenges facing the banking sector amidst economic uncertainties. Power Metal Resources (#POW) has made a strategic investment of £4 million in Apex Royalties, a private mining royalty company. This move provides Power Metal with exposure to a diversified portfolio of high-quality royalty assets across multiple commodities and jurisdictions. The positive sentiment surrounding this development suggests potential upside for Power Metal's stock.

📅 Week Ahead

24 October 2025: Shell plc (#SHEL) Completion of share buyback programme
24 October 2025: NatWest Group plc (#NWG) 2025 third quarter interim management statement
24 October 2025: AstraZeneca PLC (#AZN) TULIP-SC interim results to be presented at ACR Convergence 2025 annual meeting
24 October 2025: TwentyFour Income Ord (#TFIF) Subscription Price and results of the Issue announced
24 October 2025: Helios Underwriting plc (#HUW) General Meeting to approve tender offer

View full calendar

Market Summary